Skip to content

Edwards Lifesciences

US · EW #442 by market cap Listed 1970
101.85 -2.03 -1.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
7
■ Upgrades■ Downgrades
  • 7 upgrades vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Baird moved from Hold to Buy on 2026-11-05.

Analyst consensus 21 analysts

Buy
Avg price target 116.05 +13.9%
Price target rangecurrent 101.85
Low105.00
Avg116.05
High125.00
Buy 95% Hold 5% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-19 Leerink Partners -- Buy 116.00
2026-11-19 RBC Capital -- Buy 115.00
2026-11-16 Wells Fargo -- Buy 121.00
2026-11-11 TD Cowen -- Buy 121.00
2026-11-09 BofA Securities -- Buy --
2026-11-05 TD Cowen -- Buy 117.00
2026-11-05 Wells Fargo -- Buy 113.00
2026-11-05 Bernstein -- Hold 106.00
2026-11-05 UBS -- Buy 118.00
2026-11-05 DBS -- Buy 125.00
2026-11-05 Mizuho Securities -- Buy 120.00
2026-11-05 Piper Sandler -- Buy 115.00
2026-11-05 BofA Securities -- Buy --
2026-11-05 Baird -- Buy 116.00
2026-11-05 Evercore -- Buy 112.00
2026-11-05 Stifel -- Buy 120.00
2026-11-05 Citi -- Buy 117.00
2026-11-05 Goldman Sachs -- Buy 115.00
2026-11-05 Leerink Partners -- Buy 112.00
2026-11-05 Barclays -- Buy 120.00
2026-11-05 RBC Capital -- Buy 115.00
2026-11-05 J.P. Morgan -- Buy 120.00
2026-11-04 Wells Fargo -- Buy 113.00
2026-11-04 Citi -- Buy 117.00
2026-11-04 Barclays -- Buy 110.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-11-05 Baird Hold → Buy 116.00
2026-11-03 Truist Financial Hold → Buy 113.00
2026-07-28 UBS Hold → Buy 110.00
2026-07-24 Leerink Partners Hold → Buy 101.00
2026-04-01 Wolfe Research Hold → Buy 92.00
2026-01-09 TD Cowen Hold → Buy 97.00
2025-12-18 J.P. Morgan Hold → Buy 100.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±5.52% +1.46% (in line)
2026/Q2 2026-07-23 After close ±9.52% -1.42% (in line)
2026/Q1 2026-04-23 After close ±8.75% +5.56% (in line)
2025/Q4 2026-02-10 After close ±7.19% +2.96% (in line)
2025/Q3 2025-10-30 After close ±6.57% -1.23% (in line)
2025/Q2 2025-07-24 After close ±9.50% +5.54% (in line)
2025/Q1 2025-04-23 After close ±9.96% +6.63% (in line)
2024/Q4 2025-02-11 After close ±7.44% +6.92% (in line)
2024/Q3 2024-10-24 After close ±11.16% -1.38% (in line)
2024/Q2 2024-07-24 After close ±7.87% -31.34% (beat)
2024/Q1 2024-04-25 After close ±7.76% -1.80% (in line)
2023/Q4 2024-02-06 After close ±7.62% -1.86% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.

Edwards Lifesciences discussion 0 comments

Add a comment